Clinical, Radiometabolic and Immunologic Effects of Olaparib in Locally Advanced Triple Negative Breast Cancer: the OLTRE Window of Opportunity Trial
Frontiers in Oncology（2021）
关键词
triple negative breast cancer,window of opportunity clinical trial,neoadjuvant,BRCA,olaparib (Lynparza (TM)),TILs,PD-L1,homologous recombination deficiency
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要